MarkCadungogMD

Obstetrics & Gynecology • Newark, DE

Gynecologic Oncology

Division Director, Gynecologic Oncology Director of Robotic Surgery

Join to view full profile

Dr. Cadungog is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Cadungog's full profile

Already have an account?

Office
Christiana Care Gynecologic Oncology
4701 Ogletown Stanton Road Suite 2335
Newark, DE 19713
Phone+1 302-623-4285

Fax+1 302-623-4155
Is this information wrong?

Education & Training

University of Pennsylvania Health SystemFellowship, Gynecologic Oncology, 2008
NYU Grossman School of MedicineResidency, Obstetrics and Gynecology, 2001 - 2005
Lewis Katz School of Medicine at Temple UniversityClass of 2001

Certifications & Licensure

DE State Medical License 2008 - 2025
PA State Medical License 2005 - 2008
NY State Medical License 2004 - 2006
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Publications & Presentations

PubMed

66 citations
NAMPT Inhibition Suppresses Cancer Stem-like Cells Associated with Therapy-Induced Senescence in Ovarian Cancer
Timothy Nacarelli, Takeshi Fukumoto, Joseph A. Zundell, Nail Fatkhutdinov, Stephanie Jean, Mark G. Cadungog, Mark E. Borowsky, Rugang Zhang> ;Cancer Research. 2020 Feb 15
69 citations
EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition.
Sergey Karakashev, Takeshi Fukumoto, Bo Zhao, Jianhuang Lin, Shuai Wu, Nail Fatkhutdinov, Pyoung Hwa Park, Galina Semenova, Stephanie Jean, Mark G. Cadungog, Mark E. B...> ;Cancer Cell. 2020 Feb 10
37 citations
ARID1A promotes genomic stability through protecting telomere cohesion
Bo Zhao, Jianhuang Lin, Lijie Rong, Shuai Wu, Zhong Deng, Nail Fatkhutdinov, Joseph A. Zundell, Takeshi Fukumoto, Qin Liu, Andrew V. Kossenkov, Stephanie Jean, Mark G....> ;Nature Communications. 2019 Sep 6
31 citations
CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancer
Bipradeb Singha, Sandra L. Harper, Aaron R. Goldman, Benjamin G. Bitler, Katherine M. Aird, Mark E. Borowsky, Mark G. Cadungog, Qin Liu, Rugang Zhang, Stephanie Jean, ...> ;Scientific Reports. 2018 Oct 3
1 citations
Malignant Transformation of Endometriosis in the Ischioanal Fossa.
Jordan S. Klebanoff, Shivani K. Shah, Mark G. Cadungog> ;Case Reports in Obstetrics and Gynecology. 2018 Apr 23
70 citations
Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target.
Alfredo Perales-Puchalt, Nikolaos Svoronos, Melanie R. Rutkowski, Michael J. Allegrezza, Amelia J. Tesone, Kyle K. Payne, Jayamanna Wickramasinghe, Jenny M. Nguyen, Sh...> ;Clinical Cancer Research. 2017 Jan 15
126 citations
Tumor Cell-Independent Estrogen Signaling Drives Disease Progression Through Mobilization of Myeloid-Derived Suppressor Cells
Nikolaos Svoronos, Alfredo Perales-Puchalt, Michael J. Allegrezza, Melanie R. Rutkowski, Kyle K. Payne, Amelia J. Tesone, Jenny M. Nguyen, Tyler J. Curiel, Mark G. Cad...> ;Cancer Discovery. 2017 Jan 1
213 citations
Microbially Driven TLR5-Dependent Signaling Governs Distal Malignant Progression through Tumor-Promoting Inflammation
Melanie R. Rutkowski, Tom L. Stephen, Nikolaos Svoronos, Michael J. Allegrezza, Amelia J. Tesone, Alfredo Perales-Puchalt, Eva Brencicova, Ximena Escovar-Fadul, Jenny ...> ;Cancer Cell. 2015 Jan 12
3438 citations
Integrated genomic characterization of endometrial carcinoma
Gad Getz, Stacey Gabriel, Kristian Cibulskis, Eric S. Lander, Andrey Sivachenko, Carrie Sougnez, Michael S. Lawrence, Cyriac Kandoth, David J. Dooling, Robert S. Fulto...> ;Nature. 2013 May 2
10 citations
Tissue-based immune monitoring I: tumor core needle biopsies allow in-depth interrogation of the tumor microenvironment.
A.R. Hagemann, Mark G. Cadungog, Ian S. Hagemann, Rachel Hammond, Sarah Adams, Christina S. Chu, Stephen C. Rubin, Lin Zhang, Kathakali Addya, Michael J. Birrer, Phyll...> ;Cancer Biology & Therapy. 2011 Aug 15
17 citations
Tissue-based immune monitoring II: Multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma
A.R. Hagemann, Ian S. Hagemann, Mark G. Cadungog, Wei-Ting Hwang, Priya Patel, Priti Lal, Rachel Hammond, Phyllis A. Gimotty, Christina S. Chu, Stephen C. Rubin, Micha...> ;Cancer Biology & Therapy. 2011 Aug 15
98 citations
Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer.
Sarah Adams, Douglas A. Levine, Mark G. Cadungog, Rachel Hammond, Andrea Facciabene, Narciso Olvera, Stephen C. Rubin, Jeff Boyd, Phyllis A. Gimotty, George Coukos> ;Cancer. 2009 Jul 1
222 citations
Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss
Blaise Clarke, Anna V. Tinker, Cheng-Han Lee, Subbaya Subramanian, Matt van de Rijn, Dmitry Turbin, Steve E. Kalloger, Guangming Han, Kathy Ceballos, Mark G. Cadungog,...> ;Modern Pathology. 2009 Mar 1
4 citations
Immune prognostic factors in ovarian cancer: lessons from translational research.
Phyllis A. Gimotty, Lin Zhang, Ioannis Alagkiozidis, Mark G. Cadungog, Sarah Adams, Christina S. Chu, Dionysios Katsaros, George Coukos> ;Disease Markers. 2007 Jan 1
48 citations
Surgical resection of recurrent endometrial carcinoma.
Christopher S. Awtrey, Mark G. Cadungog, Mario M. Leitao, Kaled M. Alektiar, Carol Aghajanian, Amanda J. Hummer, Richard R. Barakat, Dennis S. Chi> ;Gynecologic Oncology. 2006 Sep 1
111 citations
Integrative Genomic Analysis of Protein Kinase C (PKC) Family Identifies PKCι as a Biomarker and Potential Oncogene in Ovarian Carcinoma
Lin Zhang, Jia Huang, Nuo Yang, Shun Liang, Andrea Barchetti, Antonis Giannakakis, Mark G. Cadungog, Ann O'Brien-Jenkins, Marco Massobrio, Katherine F. Roby, Dionyssio...> ;Cancer Research. 2006 May 1
Join now to see all